AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Press Release: Amarillo Biosciences to receive patent on solid dosage forms of interferon; company also obtains additional funding through private placement.
Amarillo Biosciences Inc (Amarillo) will soon be issued a long-sought patent for its oral formulation of interferon alpha. Now, no one else will be able to produce a lozenge or tablet with interferon alpha without risk of infringing this patent, which will provide protection for the low dose oral delivery of interferon for 17 years from the date of issue. Also Amarillo has received an additional $500,000 in funding through a private placement. The funds will supplement licence …
-
- Company to fund chicken influenza study; retains RiverStone Wealth Management.
-
News wire article from: Chemical Business Newsbase
July 7, 2006
700+ words
